Evidence map›Paper›PMID 29980437›Full record

ArticleImmunity2018

Critical Role for the Microbiota in CX

Myunghoo Kim, Carolina Galan, Andrea A Hill, Wan-Jung Wu, Hannah Fehlner-Peach, Hyo Won Song, Deborah Schady, Matthew L Bettini, Kenneth W Simpson, Randy S Longman and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 203 citations in OpenAlex.

  1. Review
  2. Antibiotics promote susceptibility tobioRxiv : the preprint server for biology · 2026
    Article
  3. Deciphering the Implications ofPathogens (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Maintenance of intestinal CX3CR1Nature communications · 2026
    Article
  6. Dietary Antigen Interaction with Intestinal Epithelial Cells.Current allergy and asthma reports · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Microbiota interaction with Tregs: a target for colitis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Myunghoo KimAlkek Center for Metagenomics and Microbiome Research and the Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
Carolina GalanThe Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Andrea A HillAlkek Center for Metagenomics and Microbiome Research and the Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
Wan-Jung WuAlkek Center for Metagenomics and Microbiome Research and the Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
Hannah Fehlner-PeachThe Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Hyo Won SongAlkek Center for Metagenomics and Microbiome Research and the Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
Deborah SchadyDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
Matthew L BettiniDepartment of Pediatrics, Section of Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA; Biology of Inflammation Center, Baylor College of Medicine, Houston, TX 77030, USA.
Kenneth W SimpsonCollege of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Randy S LongmanJill Roberts Center for IBD Research and Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY 10021, USA.
Dan R LittmanThe Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, New York, NY 10016, USA.
Gretchen E DiehlAlkek Center for Metagenomics and Microbiome Research and the Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA; Biology of Inflammation Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: gdiehl@bcm.edu.
Baylor College of Medicine · USNew York University · USCornell University · USHoward Hughes Medical Institute · USWeill Cornell Medicine · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Immunology Scientist Training ProgramT32AI053831 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2003 to 2018
$4.2M
Orchestrating intestinal immunity through microbiota-CX3CR1+ cell interactions R01AI125264 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI GRETCHEN E DIEHL · 2017 to 2026
$4.1M
Host-Microbiota Interactions in Crohn's Disease-associated SpondyloarthritisR01DK114252 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI LONGMAN, RANDY S · 2018 to 2022
$1.9M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
Commensal-dependent induction of protective immunityR21AI123945 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI DIEHL, GRETCHEN E · 2017 to 2018
$391k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA125123NCRR NIH HHS S10 RR024574NIAID NIH HHS P30 AI036211NIAID NIH HHS R01 AI125264NIAID NIH HHS R21 AI123945NIAID NIH HHS T32 AI053831NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK114252
6 · The paper itself

Abstract

The intestinal barrier is vulnerable to damage by microbiota-induced inflammation that is normally restrained through mechanisms promoting homeostasis. Such disruptions contribute to autoimmune and inflammatory diseases including inflammatory bowel disease. We identified a regulatory loop whereby, in the presence of the normal microbiota, intestinal antigen-presenting cells (APCs) expressing the chemokine receptor CX

Indexed as

AnimalsAntigen PresentationBacterial AdhesionCX3C Chemokine Receptor 1Disease Models, AnimalFemaleGastrointestinal MicrobiomeHomeostasisImmune ToleranceImmunity, MucosalInflammationInflammatory Bowel DiseasesInterleukin-10Intestinal MucosaMaleMiceCX3C Chemokine Receptor 1Cx3cr1 protein, mouseIL10 protein, mouseInterleukin-10AIEC E. coliIL-10intestinal immunitymicrobiotamononuclear phagocytesoral toleranceSalmonellaTh1

Identifiers

PMID29980437
PMCPMC6051886
OpenAlexW2811023043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.